Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

PureTech Health plc - American Depositary Shares (NQ:PRTC)

18.05 UNCHANGED
Streaming Delayed Price Updated: 3:58 PM EDT, Apr 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about PureTech Health plc - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
PureTech-Invented KarXT Receives U.S. Food and Drug Administration Approval for the Treatment of Schizophrenia in Adults
From PureTech Health plc
Via Business Wire
News headline image
Rubrik Reports Q2 Results, Joins Ionis Pharmaceuticals, Hewlett Packard Enterprise And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
PureTech Founded Entity Vor Bio Announces New Clinical Data Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies
From PureTech Health plc
Via Business Wire
News headline image
Boeing, Dyne Therapeutics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
PureTech Health plc – Half-Year Report
From PureTech Health plc
Via Business Wire
News headline image
Galapagos, XPeng, CorMedix And Other Big Stocks Moving Higher On Monday ↗
 
Via Benzinga
News headline image
PureTech Appoints Michele Holcomb, PhD, to Board of Directors
From PureTech Health plc
Via Business Wire
News headline image
PureTech Health: Notice of Half-Yearly Results
From PureTech Health plc
Via Business Wire
News headline image
PureTech Founded Entity Seaport Therapeutics Appoints David Wheadon, M.D., to its Board of Directors
From PureTech Health plc
Via Business Wire
News headline image
PureTech Founded Entity Vedanta Biosciences Expands Leadership Team and Appoints Head of Commercial
From PureTech Health plc
Via Business Wire
News headline image
PureTech Health: Completion of Tender Offer & Total Voting Rights
From PureTech Health plc
Via Business Wire
News headline image
PureTech Health: Results of the Tender Offer
From PureTech Health plc
Via Business Wire
News headline image
PureTech Announces Change of Board Role
From PureTech Health plc
Via Business Wire
News headline image
PureTech Founded Entity Seaport Therapeutics Appoints Seasoned Executives to Management Team
From PureTech Health plc
Via Business Wire
News headline image
PureTech Health: Results of Annual General Meeting
From PureTech Health plc
Via Business Wire
News headline image
PureTech Health: Result of General Meeting
From PureTech Health plc
Via Business Wire
News headline image
PureTech Founded Entity Akili Interactive and Virtual Therapeutics Announce Entering Into Definitive Merger Agreement to Establish Leading Digital Health Company
From PureTech Health plc
Via Business Wire
News headline image
PureTech to Present at the Jefferies Global Healthcare Conference
From PureTech Health plc
Via Business Wire
News headline image
PureTech Founded Entity Vedanta Biosciences Enrolls First Patient in Pivotal Phase 3 RESTORATiVE303 Study of VE303 for the Prevention of Recurrent C. difficile Infection
From PureTech Health plc
Via Business Wire
News headline image
PureTech Health: Launch of Proposed $100 Million Tender Offer at 250 Pence Per Ordinary Share
From PureTech Health plc
Via Business Wire
News headline image
PureTech Founded Entity Seaport Therapeutics Presents Data from Multiple SPT-300 Trials at Society of Biological Psychiatry (SOBP) Annual Meeting
From PureTech Health plc
Via Business Wire
News headline image
PureTech Founded Entity Seaport Therapeutics Adds Industry Veteran to Board of Directors and Makes Key Executive Appointments
From PureTech Health plc
Via Business Wire
News headline image
PureTech Announces Annual Results for Year Ended December 31, 2023
From PureTech Health plc
Via Business Wire
News headline image
PureTech Health: Notice of Results
From PureTech Health plc
Via Business Wire
News headline image
PureTech Announces Completion of Enrollment in Phase 2b ELEVATE IPF Trial of LYT-100 (Deupirfenidone) in Idiopathic Pulmonary Fibrosis
From PureTech Health plc
Via Business Wire
News headline image
PureTech Receives FDA Fast Track Designation for LYT-200 in Head and Neck Cancers
From PureTech Health plc 
Via Business Wire
News headline image
PureTech Launches Seaport Therapeutics with $100 Million Oversubscribed Series A and Announces Management Transitions
From PureTech Health plc
Via Business Wire
News headline image
PureTech Proposes $100 Million Capital Return
From PureTech Health plc
Via Business Wire
News headline image
Bristol Myers Squibb Completes Acquisition of PureTech's Founded Entity Karuna Therapeutics for $14 Billion
From PureTech Health plc
Via Business Wire
News headline image
PureTech Receives Orphan Drug Designation for LYT-200 in Acute Myeloid Leukemia
From PureTech Health plc
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.